During a heart attack, blood stops flowing into the heart; starved for oxygen, part of the heart muscle dies. The heart muscle does not regenerate; instead it replaces dead tissue with scars made of cells called fibroblasts that do not help the heart pump. The heart weakens; most people who had a severe heart attack will develop heart failure, which remains the leading cause of mortality from heart disease.
“Our approach is to restore cardiac function by reprogramming scar tissue into cardiomyocytes.”
In the Laboratory for Cardiac Regeneration, led by Dr. Todd K. Rosengart, professor and chair of surgery and professor of molecular and cellular biology at Baylor, a team of researchers has shown that administration of a cocktail made of transcription factors Gata4, Mef2c and Tbx5 (GMT) results in less scar tissue, or fibrosis, and up to a 50 percent increase in cardiac function in small animal models of the disease.
This result was presumed to be mostly a consequence of the reprograming of heart fibroblasts into cardiomyocyte-like cells. Interestingly, the Rosengart team noticed that reduced fibrosis and improved cardiac function far exceeded the extent of induced new cardiomyocyte-like cells.
“This observation suggested the existence of unexplored and non-optimized underlying mechanisms,” Rosengart said.
A novel role for Gata4
“We and others had described that, in addition to inducing reprograming of fibroblasts into cardiomyocyte-like cells, the GMT cocktail also induced reduction of post-heart attack fibrosis,” Mathison said. “However, not much attention had been paid to the latter.”
The research team investigated in more detail how the GMT cocktail activated mechanisms that reduced fibrosis. They found the first evidence that, of the three components in the GMT cocktail, only Gata4 was able to reduce post-heart attack fibrosis and improve cardiac function in a rat model of heart attack.
Further exploration of the molecular mechanism mediating this novel effect showed that administering Gata4 to rat fibroblasts in the lab resulted in reduced expression of Snail, the master gene of fibrosis.
“Gata4 plays a complex role in heart regeneration: as part of the GMT cocktail, it contributes to the reprograming of fibroblasts into cardiomyocyte-like cells; we know it contributes to heart hypertrophy – the development of an enlarged heart – and now we discovered that it alone can decrease cardiac fibrosis,” Mathison said. “Others have reported that Gata4 also can suppress liver fibrosis. There is still a lot to be done before we can transfer these discoveries to the bedside, but they are important first steps.”
Rosengart also is professor of heart and vascular disease at the Texas Heart Institute.
Read all the details of this study in the Journal of Thoracic and Cardiovascular Surgery.
Other contributors to this work include Vivek P. Singh, Deepthi Sanagasetti, Lina Yang, Jaya Pratap Pinnamaneni and Jianchang Yang, all at Baylor College of Medicine.
Financial support was provided by a National Institutes of Health RO1 grant.